Pharma's Almanac

4258 Articles Available

1 178

Medical Professionals Across Merck, Pfizer, and Eli Lilly Volunteer Amid COVID-19 Pandemic

Gilead Sciences Statement on Access to Remdesivir Outside of Clinical Trials

PR-M04-20-NI-003

Social Distancing

Caidr-Intuitive App to Help People Better Understand Impact of Social Distancing

PR-M04-20-NI-002

Fermentation

Lux Research Predicts Synthetic Biology Has High Potential as an Alternative Production Method for Chemicals

PR-M04-20-NI-001

Vaccine

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

PR-M03-20-NI-045

COVID-19

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19

PR-M03-20-NI-046

FDA

FDA Expedites Review of Diagnostic Tests to Combat COVID-19

PR-M03-20-NI-043

Biohaven to Advance Vazegepant Into Phase 3 for Acute Migraine Treatment

M&A

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

PR-M03-20-NI-041

Medical Device Production

Ford Works With 3M, GE, UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients

PR-M03-20-NI-040

COVID-19 Test

Mesa Biotech Receives Emergency Use Authorization from FDA for a 30 Minute Point of Care Molecular COVID-19 Test

PR-M03-20-NI-039

FDA Takes Action to Increase U.S. Supplies Through Instructions for PPE and Device Manufacturers

PR-M03-20-NI-038

Drug Supply

BeiGene Announces Supply Update for ABRAXANE in China

PR-M03-20-NI-037

Supply Chain

Yourway – The Biopharma Services Company – Keeps Up With Covid-19, Providing Direct-to-Patient (DTP) Services Globally

PR-M03-20-NI-035

Biosecurity

iBio Joins the Alliance for Biosecurity

PR-M03-20-NI-038

COVID-19 Vaccine

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

PR-M03-20-NI-037

PR-M03-20-NI-036

Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy

PR-M03-20-NI-036

Pharma Equipment

PHARMA FACILITY OPPORTUNITY ALERT: Pharmaceutical Grade Facility Available For Sale Or Lease

PR-M03-20-NI-034

M&A

M&A: Fundamental to Pharma Industry Growth

PAP-Q1-20-NI-002

FDA

FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus

PR-M03-20-NI-032

Supply Chain

GE Healthcare Increases Production to Aid Coronavirus Patients

PR-M03-20-NI-033

Vaccine

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

PR-M03-20-NI-031

Nice Insight Overview

Understanding a Dynamic Industry Through Mergers and Acquisitions

PAP-Q1-20-NI-001

Pharmaceutics Know-How

Pharmaceutics Know-How and Service Excellence to Re-Energize a CDMO

PAP-Q1-20-CL-001

1 178

»